$46.55
N/A
Last update: Nov 6, 4:00 PM

The average analyst price target for Spruce Biosciences is $156.05, 235.2% above the current price. Of 12 analysts, 10 rate it Buy and 2 Hold. Targets range from $37.50 to $283. The latest change came on Sep 17, 2026, when Lake Street initiated coverage of Spruce Biosciences with a Buy rating and a $149 price target.
Price Target Range — 10 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months